MedTrace Logo

Studies on Adsorption International Learning Initiative Global

NCT07123909 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-12-10

No results posted yet for this study

Summary

Use of sorption technologies in patients undergoing maintenance hemodialysis with inflammatory syndrome and clinical manifestations of uremia

Conditions

  • CKD (Chronic Kidney Disease) Stage 5D
  • Uremia; Chronic
  • Uremic; Toxemia
  • Inflammation Chronic
  • Hemodialysis
  • Inflammation Biomarkers
  • Dialysis Related Complication
  • Anemia Associated With End Stage Renal Disease

Interventions

DEVICE

Patients will undergo a combined hemodialysis and hemosorption procedure. The study cartridge for hemosorption by Jafron HA130 contains the original adsorbing material.

The test cartridge will be used in addition to the ongoing program hemodialysis three times a week in the first month, twice a week in the next month, once a week in the third month

Sponsors & Collaborators

  • Botkin Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2026-03-31
Completion
2026-06-30

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07123909 on ClinicalTrials.gov